Reduced serum dopamine-β-hydroxylase activity in paranoid schizophrenics

M. Arato, G. Bagdy, F. Blumel

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The serum dopamine-beta-hydroxylase activity of 134 carefully selected paranoid schizophrenic patients was compared with that of 118 normal controls. Significantly reduced serum DBH activity found in the schizophrenic group in comparison to the control group could not be brought into relationship withe the patient's age, nor with neuroleptic treatment. Manic depressive patients showed values similar to the normal control group. It is discussed that mainly genetically determined low serum DBH activity may be related to the hyperdopaminergic pathomechanism of paranoid schizophrenia.

Original languageEnglish
Pages (from-to)19-22
Number of pages4
JournalPharmacopsychiatria
Volume6
Issue number1
Publication statusPublished - 1983

Fingerprint

Mixed Function Oxygenases
Dopamine
Serum
Paranoid Schizophrenia
Dopamine beta-Hydroxylase
Control Groups
Antipsychotic Agents
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Reduced serum dopamine-β-hydroxylase activity in paranoid schizophrenics. / Arato, M.; Bagdy, G.; Blumel, F.

In: Pharmacopsychiatria, Vol. 6, No. 1, 1983, p. 19-22.

Research output: Contribution to journalArticle

@article{161ce19f9e9c4edb9f3f7f21fc9dd0fa,
title = "Reduced serum dopamine-β-hydroxylase activity in paranoid schizophrenics",
abstract = "The serum dopamine-beta-hydroxylase activity of 134 carefully selected paranoid schizophrenic patients was compared with that of 118 normal controls. Significantly reduced serum DBH activity found in the schizophrenic group in comparison to the control group could not be brought into relationship withe the patient's age, nor with neuroleptic treatment. Manic depressive patients showed values similar to the normal control group. It is discussed that mainly genetically determined low serum DBH activity may be related to the hyperdopaminergic pathomechanism of paranoid schizophrenia.",
author = "M. Arato and G. Bagdy and F. Blumel",
year = "1983",
language = "English",
volume = "6",
pages = "19--22",
journal = "Pharmacopsychiatry",
issn = "0176-3679",
publisher = "Georg Thieme Verlag",
number = "1",

}

TY - JOUR

T1 - Reduced serum dopamine-β-hydroxylase activity in paranoid schizophrenics

AU - Arato, M.

AU - Bagdy, G.

AU - Blumel, F.

PY - 1983

Y1 - 1983

N2 - The serum dopamine-beta-hydroxylase activity of 134 carefully selected paranoid schizophrenic patients was compared with that of 118 normal controls. Significantly reduced serum DBH activity found in the schizophrenic group in comparison to the control group could not be brought into relationship withe the patient's age, nor with neuroleptic treatment. Manic depressive patients showed values similar to the normal control group. It is discussed that mainly genetically determined low serum DBH activity may be related to the hyperdopaminergic pathomechanism of paranoid schizophrenia.

AB - The serum dopamine-beta-hydroxylase activity of 134 carefully selected paranoid schizophrenic patients was compared with that of 118 normal controls. Significantly reduced serum DBH activity found in the schizophrenic group in comparison to the control group could not be brought into relationship withe the patient's age, nor with neuroleptic treatment. Manic depressive patients showed values similar to the normal control group. It is discussed that mainly genetically determined low serum DBH activity may be related to the hyperdopaminergic pathomechanism of paranoid schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0020687043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020687043&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 19

EP - 22

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

SN - 0176-3679

IS - 1

ER -